Events
These events and webinars are intended for veterinary professionals only.
If You're Not Seeing Canine Lymphoma Cases, They Might Be Seeing You! #24294
Speaker:
Natalie Marks, DVM, CVJ
In this 1-hour virtual live lecture, Dr. Marks will start with a quick review of the prevalence of canine lymphoma and why early diagnosis is critical. The bulk of the lecture will focus on five critical areas the veterinary team can focus on for earlier diagnostics and education to pet parents. This includes at-risk breeds, questions to ask in the history, commonly missed clinical signs, subtle physical exam findings that dictate further diagnostics, and recommended workup options (including the spectrum of care.) The final sections of this presentation will discuss how to utilize resources for efficient and effective communication in your practice.
07:00 PM EDT
RACE# 27059-1174212
1 RACE-Approved Credit Hour
Tuesday, October 29, 2024, 19:00 - 20:00
location_on Virtual Meeting
Drug Laws and Regulations for Everyday Practice #24298
Speaker:
Rikki Horne, PharmD, DICVP, FSVHP
This presentation will be given by a pharmacist who specializes in veterinary pharmacology. The Presenter will discuss the history of veterinary drug laws and identify FDA-approved veterinary medications. The presenter will go on to compare and contrast the different regulatory bodies in veterinary pharmaceuticals and how this differs from human pharmaceuticals. Finally, the presenter will focus on labeling requirements that would apply to most state pharmacy and veterinary laws. This presentation will fulfill drug law requirements for continuing education as set by state veterinary medical boards.
07:00 PM EDT
RACE# 27059-1206490
1 RACE-Approved Credit Hour
Wednesday, October 30, 2024, 19:00 - 20:00
location_on Virtual Meeting
Update on the Use of Bisphosphonates in Horses #24322
Speaker:
Greg Schmid, DVM
After nearly a decade of FDA-approval of non-nitrogenous bisphosphonates for use in horses, this presentation is meant to review our current understanding of these drugs and introduce newly available scientific data and research. Topics will include clinical efficacy data, pharmacokinetic studies, equine safety studies, and recently discovered effects in non-bone cells. To conclude, there will be an overview of some recent and relevant non-nitrogenous bisphosphonate clinical trials. Bisphosphates are a unique drug class with new discoveries regularly occurring in both human and veterinary medicine. This presentation will give attendees an opportunity to review previously known information and learn about recent developments in this drug class. This practical knowledge can be applied in the clinical setting when considering the use of bisphosphonate drugs in equine patients.
07:00 PM EST
RACE# 27059-933819
1 RACE-Approved Credit Hour
Wednesday, November 6, 2024, 19:00 - 20:00
location_on Virtual Meeting
Zennovation in Sedation: Rethinking What is Possible #24545
Speaker:
Katie Marcus, DVM
In this educational presentation, we will introduce the concept of procedural sedation in veterinary practice. This includes a review of the basic physiology behind sedation in dogs, commonly-used sedatives, and the use of a reversal agent. Lastly, we will discuss a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan – and how it can improve your clinical practice.
07:00 PM PST
RACE# 27059-918761
1 RACE-Approved Credit Hour
Wednesday, November 6, 2024, 19:00 - 20:00
location_on Dinner Meeting, Seattle, WA
Verdinexor: A Novel Oral Therapy for Canine Lymphoma #24323
Speaker:
Pam Mitchell, MS, DVM
This presentation will focus on the novel class of drugs called SINE inhibitors and review SINE mechanism of action. We will also look at where this oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor their lymphoma patient on verdinexor, including how to address any potential adverse events.
12 PM EST
1 RACE-Approved Credit
RACE# 27059-900255
Thursday, November 7, 2024, 12:00 - 01:00
location_on Virtual Meeting
Zennovation in Sedation: Rethinking What is Possible #24529
Speaker:
Katie Marcus, DVM
In this educational presentation, we will introduce the concept of procedural sedation in veterinary practice. This includes a review of the basic physiology behind sedation in dogs, commonly-used sedatives, and the use of a reversal agent. Lastly, we will discuss a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan – and how it can improve your clinical practice.
07:00 PM PST
RACE# 27059-918761
1 RACE-Approved Credit Hour
Thursday, November 7, 2024, 19:00 - 20:00
location_on Dinner Meeting, Woodinville, WA
Zennovation in Sedation: Rethinking What is Possible #24540
Speaker:
James Sturzione, DVM, MBS
In this educational presentation, we will introduce the concept of procedural sedation in veterinary practice. This includes a review of the basic physiology behind sedation in dogs, commonly-used sedatives, and the use of a reversal agent. Lastly, we will discuss a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan – and how it can improve your clinical practice.
06:30 PM EST
RACE# 27059-918761
1 RACE-Approved Credit Hour
Tuesday, November 12, 2024, 18:30 - 19:30
location_on Dinner Meeting, Portland, ME
Leveraging Procedural Sedation for Canine Patients #24563
Speaker:
Kasey Crabb, DVM
Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic. Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic.
6:30 PM CST
1 RACE-Approved Credit
Tuesday, November 12, 2024, 18:30 - 19:30
location_on Dinner Meeting, Starkville, MS
Did I Enter Appropriately... DEA Controlled Substance Recordkeeping Requirements #24324
Speaker:
Rikki Horne, PharmD, DICVP, FSVHP
This presentation will be given by a pharmacist who specializes in veterinary pharmacology. The presenter will discuss the record-keeping requirements for DEA-controlled drugs. The presenter will also discuss the various classifications of drugs and how some states classify them differently. Finally, the presenter will discuss the differences in logging and inventory management to meet the requirements of DEA logging CE for every state. This presentation will also fulfill the requirements of DEA logging CE in each state, including Florida.
07:00 PM EST
RACE# 27059-1206498
1 RACE-Approved Credit Hour
Tuesday, November 12, 2024, 19:00 - 20:00
location_on Virtual Meeting
Verdinexor: A Novel Oral Therapy for Canine Lymphoma #24431
Speaker:
Elizabeth Mongol-Gunter, VMD
This presentation will focus on the novel class of drugs called SINE inhibitors and review SINE mechanism of action. We will also look at where this oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor their lymphoma patient on verdinexor, including how to address any potential adverse events.
7 PM EST
1 RACE-Approved Credit
RACE# 27059-900255
Tuesday, November 12, 2024, 19:00 - 20:00
location_on Dinner Meeting, Lynchburg, VA
Verdinexor: A Novel Oral Therapy for Canine Lymphoma #24549
Speaker:
Kathy Engler, DVM, DABVP
This presentation will focus on the novel class of drugs called SINE inhibitors and review SINE mechanism of action. We will also look at where this oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor their lymphoma patient on verdinexor, including how to address any potential adverse events.
7 PM CST
1 RACE-Approved Credit
RACE# 27059-900255
Tuesday, November 12, 2024, 19:00 - 20:00
location_on Dinner Meeting, Grand Island, NE
Leveraging Procedural Sedation for Canine Patients #24564
Speaker:
Kasey Crabb, DVM
Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic. Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic.
6:30 PM CST
1 RACE-Approved Credit
Wednesday, November 13, 2024, 18:30 - 19:30
location_on Dinner Meeting, Biloxi, MS
Leveraging Procedural Sedation for Canine Patient #24432
Speaker:
Elizabeth Mongol-Gunter, VMD
Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic. Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic.
7:00 PM EDT
1 RACE-Approved Credit
Wednesday, November 13, 2024, 19:00 - 20:00
location_on Dinner Meeting, Roanoke, VA
Leveraging Procedural Sedation for Canine Patients #24551
Speaker:
Jennifer Kasten, DVM
Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic. Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic.
7:00 PM EST
1 RACE-Approved Credit
Wednesday, November 13, 2024, 19:00 - 20:00
location_on Dinner Meeting, West Chester Township, OH
Leveraging Procedural Sedation for Canine Patients #24550
Speaker:
Kathy Engler, DVM, DABVP
Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic. Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic.
7:00 PM CST
1 RACE-Approved Credit
Wednesday, November 13, 2024, 19:00 - 20:00
location_on Dinner Meeting, Kearney, NE
Leveraging Procedural Sedation for Canine Patients #24547
Speaker:
Gregory Long, DVM
Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic. Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic.
7:00 PM EST
1 RACE-Approved Credit
Wednesday, November 13, 2024, 19:00 - 20:00
location_on Dinner Meeting, Clemson, SC
Managing Chronic Kidney Disease in Canines and Felines- Pitfalls and Updated Standards of Practice #24325
Speaker:
Corinne Goldman, DVM, MS, DACVIM (SAIM)
This presentation will discuss the diagnosis and management of both canine and feline chronic kidney disease (CKD). The presenter will discuss the chronic care of animals with CKD and common pitfalls seen in the management of these diseases. Presenter will also discuss pharmaceuticals and nutraceuticals that are often used to manage kidney health. Finally, the updated standards of practice will be given
7:00 PM EST
1 RACE-Approved Credit Hour
RACE# 27059-1206504
Thursday, November 14, 2024, 19:00 - 20:00
location_on Virtual Meeting
Leveraging Procedural Sedation for Canine Patient #24433
Speaker:
Elizabeth Mongol-Gunter, VMD
Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic. Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic.
7:00 PM EST
1 RACE-Approved Credit
Thursday, November 14, 2024, 19:00 - 20:00
location_on Dinner Meeting, Staunton, VA
Canine Regenerative Therapy- Autologous Blood Products #24344
Speaker:
Timothy Smaha, DVM
The presenter reviews canine regenerative therapy. Focus areas include basic principles of regenerative medicine, FDA regulations, and types of autologous blood products. The types of medical devices necessary for processing autologous blood products including centrifugation, filtration, and incubation are all discussed. Additionally a review of current literature on validation of different autologous products in canines and felines will be discussed. Finally there will be a review of the current literature on the uses of Platelet rich plasma in small animal medicine and an overview of how to perform joint injections for companion animals.
12:00 PM EDT
1 RACE-Approved Credit Hour
Tuesday, November 19, 2024, 12:00 - 01:00
location_on Virtual Meeting
Zennovation in Sedation: Rethinking What is Possible #24572
Speaker:
Gregory Long, DVM
In this educational presentation, we will introduce the concept of procedural sedation in veterinary practice. This includes a review of the basic physiology behind sedation in dogs, commonly-used sedatives, and the use of a reversal agent. Lastly, we will discuss a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan – and how it can improve your clinical practice.
07:00 PM CST
RACE# 27059-918761
1 RACE-Approved Credit Hour
Tuesday, November 19, 2024, 19:00 - 20:00
location_on Dinner Meeting, Auburn, AL
Zennovation in Sedation: Rethinking What is Possible #24326
Speaker:
Leah Braas, DVM, CVA
In this educational presentation, we will introduce the concept of procedural sedation in veterinary practice. This includes a review of the basic physiology behind sedation in dogs, commonly-used sedatives, and the use of a reversal agent. Lastly, we will discuss a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan – and how it can improve your clinical practice.
Veterinarians and Technicians are invited.
02:00 PM EST
RACE# 27059-918761
1 RACE-Approved Credit Hour
Wednesday, November 20, 2024, 14:00 - 15:00
location_on Virtual Meeting
Equine Osteoarthritis and Chondroprotective Therapies #24327
Speaker:
Hadley Whiting, DVM
The presenter reviews canine regenerative therapy. Focus areas include basic principles of regenerative medicine, FDA regulations, and types of autologous blood products. The types of medical devices necessary for processing autologous blood products including centrifugation, filtration, and incubation are all discussed. Additionally a review of current literature on validation of different autologous products in canines and felines will be discussed. Finally there will be a review of the current literature on the uses of Platelet rich plasma in small animal medicine and an overview of how to perform joint injections for companion animals.
Veterinarians and Technicians are invited.
07:00 PM EDT
1 RACE-Approved Credit Hour
Wednesday, November 20, 2024, 19:00 - 20:00
location_on Virtual Meeting
Leveraging Procedural Sedation for Canine Patients #24560
Speaker:
Kathy Engler, DVM, DABVP
Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic. Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic.
7:00 PM CST
1 RACE-Approved Credit
Wednesday, November 20, 2024, 19:00 - 20:00
location_on Dinner Meeting, West Fargo, ND
Zennovation in Sedation: Rethinking What is Possible #24575
Speaker:
James Sturzione, DVM, MBS
In this educational presentation, we will introduce the concept of procedural sedation in veterinary practice. This includes a review of the basic physiology behind sedation in dogs, commonly-used sedatives, and the use of a reversal agent. Lastly, we will discuss a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan – and how it can improve your clinical practice.
07:00 PM EST
RACE# 27059-918761
1 RACE-Approved Credit Hour
Wednesday, November 20, 2024, 19:00 - 20:00
location_on Dinner Meeting, Concord, NH
Managing and Treating Canine Hypoadrenocorticism (Addison's Disease) #24328
Speaker:
Pam Mitchell, MS, DVM
This presentation provides a review of Canine Hypoadrenocorticism (Addison’s Disease); the topics include pathophysiology, signalment, clinical signs, diagnostics, treatment, and monitoring. Cases will be discussed to reinforce your diagnostic confidence.
Veterinarians and Technicians are invited.
07:00 PM EST
1 RACE-Approved Credit Hour
Thursday, November 21, 2024, 19:00 - 20:00
location_on Virtual Meeting
Zennovation in Sedation: Rethinking What is Possible #24567
Speaker:
Sam Gindville, DVM
In this educational presentation, we will introduce the concept of procedural sedation in veterinary practice. This includes a review of the basic physiology behind sedation in dogs, commonly-used sedatives, and the use of a reversal agent. Lastly, we will discuss a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan – and how it can improve your clinical practice.
07:00 PM EST
RACE# 27059-918761
1 RACE-Approved Credit Hour
Thursday, November 21, 2024, 19:00 - 20:00
location_on Dinner Meeting, Sarasota, FL
Verdinexor: A Novel Oral Therapy for Canine Lymphoma #24573
Speaker:
Gregory Long, DVM
This presentation will focus on the novel class of drugs called SINE inhibitors and review SINE mechanism of action. We will also look at where this oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor their lymphoma patient on verdinexor, including how to address any potential adverse events.
7 PM CST
1 RACE-Approved Credit
RACE# 27059-900255
Thursday, November 21, 2024, 19:00 - 20:00
location_on Dinner Meeting, Montgomery, AL
Management of the Canine Cushingoid Diabetic #24329
Speaker:
Andrew Bugbee, DVM, DACVIM SAIM
The program will walk through the diagnostics and management of a dog with hyperadrenocorticism and diabetes mellitus. Preferred diagnostic testing, medical management, and alterations to the dosing regimen based on disease state will be addressed. Finally, the presenter will offer cases and examples of how to manage a dog with both comorbidities.
7:00 PM EST
RACE# 27059-1206516
1 RACE-Approved Credit Hour
Tuesday, December 3, 2024, 19:00 - 20:00
location_on Virtual Meeting
Canine Regenerative Therapy- Autologous Blood Products #24345
Speaker:
Timothy Smaha, DVM
The presenter reviews canine regenerative therapy. Focus areas include basic principles of regenerative medicine, FDA regulations, and types of autologous blood products. The types of medical devices necessary for processing autologous blood products including centrifugation, filtration, and incubation are all discussed. Additionally a review of current literature on validation of different autologous products in canines and felines will be discussed. Finally there will be a review of the current literature on the uses of Platelet rich plasma in small animal medicine and an overview of how to perform joint injections for companion animals.
3:00 PM EDT
1 RACE-Approved Credit Hour
Thursday, December 5, 2024, 15:00 - 16:00
location_on Virtual Meeting
Zennovation in Sedation: Rethinking What is Possible #24331
Speaker:
Katie Marcus, DVM
In this educational presentation, we will introduce the concept of procedural sedation in veterinary practice. This includes a review of the basic physiology behind sedation in dogs, commonly-used sedatives, and the use of a reversal agent. Lastly, we will discuss a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan – and how it can improve your clinical practice.
07:00 PM EST
RACE# 27059-918761
1 RACE-Approved Credit Hour
Tuesday, December 10, 2024, 19:00 - 20:00
location_on Virtual Meeting
Update on Managing Canine Hyperadrenocorticism #24332
Speaker:
Lauren DiMarzio, DVM
Canine Hyperadrenocorticism (Cushing’s Disease) can be a challenging yet rewarding disease to manage. This presentation will review all aspects of Cushing’s: basic pathophysiology, clinical signs, diagnostics, differentiating tests, treatment and monitoring. A series of cases to increase understanding of managing Cushing’s patients will be presented and the final section highlights ways to enhance owner compliance.
02:00 PM EST
RACE# 27059-1119546
1.5 RACE-Approved Credit Hour
Wednesday, December 11, 2024, 14:00 - 15:30
location_on Virtual Meeting
Canine Regenerative Therapy- Autologous Blood Products #24346
Speaker:
Katie Marcus, DVM
The presenter reviews canine regenerative therapy. Focus areas include basic principles of regenerative medicine, FDA regulations, and types of autologous blood products. The types of medical devices necessary for processing autologous blood products including centrifugation, filtration, and incubation are all discussed. Additionally a review of current literature on validation of different autologous products in canines and felines will be discussed. Finally there will be a review of the current literature on the uses of Platelet rich plasma in small animal medicine and an overview of how to perform joint injections for companion animals.
7:00 PM EDT
1 RACE-Approved Credit Hour
Wednesday, December 11, 2024, 19:00 - 20:00
location_on Virtual Meeting
Challenging Euthanasia Cases and Preventing Dysthanasia #24333
Speaker:
Kathleen Cooney, DVM, CHPV, DACAW Resident
Every one of us wants euthanasia procedures to go well. A dysthanasia is the opposite of a good death or a death where the quality of life is not considered. What is and isnt considered a good death is complicated. In this session, we review how pet owners and veterinarians define a good death and have a deeper understanding of what is and is not good in the owners eyes. We can then determine how best to address dysthanasias when they happen, to protect the mental health of loved ones and the veterinary team. Dysthanasias are upsetting, and how we handle them when they occur makes all the difference. There will be time to talk through challenging cases.
08:00 PM EST
RACE# 27059-1206526
1 RACE-Approved Credit Hour
Thursday, December 12, 2024, 20:00 - 21:00
location_on Virtual Meeting
Verdinexor: A Novel Oral Therapy for Canine Lymphoma #24577
Speaker:
Jennifer Kasten, DVM
This presentation will focus on the novel class of drugs called SINE inhibitors and review SINE mechanism of action. We will also look at where this oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor their lymphoma patient on verdinexor, including how to address any potential adverse events.
7 PM EST
1 RACE-Approved Credit
RACE# 27059-900255
Tuesday, December 17, 2024, 19:00 - 20:00
location_on Dinner Meeting, Fairlawn, OH
Leveraging Procedural Sedation for Canine Patient #24578
Speaker:
Jennifer Kasten, DVM
Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic. Procedural sedation is often an underutilized tool for small practitioners. This educational program will demystify the concept of procedural sedation and its use in dogs. Detailed information on a novel sedative, a combination of the alpha-2-agonist, medetomidine, with the peripheral alpha-2 antagonist, vatinoxan will be provided. Real-world cases highlighting the use of this sedative will demonstrate how to leverage procedural sedation in your clinic.
7:00 PM EST
1 RACE-Approved Credit
Wednesday, December 18, 2024, 19:00 - 20:00
location_on Dinner Meeting, Twinsburg, OH